Your browser doesn't support javascript.
loading
Implementing harm reduction kits in an office-based addiction treatment program.
Shang, Margaret; Thiel, Brent; Liebschutz, Jane M; Kraemer, Kevin L; Freund, Ariana; Jawa, Raagini.
Afiliación
  • Shang M; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Thiel B; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Liebschutz JM; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Kraemer KL; Center for Research on Healthcare, University of Pittsburgh School of Medicine, 3609 Forbes Ave, Pittsburgh, PA, 15213, USA.
  • Freund A; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Jawa R; Center for Research on Healthcare, University of Pittsburgh School of Medicine, 3609 Forbes Ave, Pittsburgh, PA, 15213, USA.
Harm Reduct J ; 20(1): 163, 2023 11 02.
Article en En | MEDLINE | ID: mdl-37919741
ABSTRACT

BACKGROUND:

The rising rates of drug use-related complications call for a paradigm shift in the care for people who use drugs. While addiction treatment and harm reduction have historically been siloed in the US, co-location of these services in office-based addiction treatment (OBAT) settings offers a more realistic and patient-centered approach. We describe a quality improvement program on integrating harm reduction kits into an urban OBAT clinic.

METHODS:

After engaging appropriate stakeholders and delivering clinician and staff trainings on safer use best practices, we developed a clinical workflow for universal offering and distribution of pre-packaged kits coupled with patient-facing educational handouts. We assessed (1) kit uptake with kit number and types distributed; and (2) implementation outcomes of feasibility, acceptability, appropriateness, and patient perceptions.

RESULTS:

One-month post-implementation, 28% (40/141) of completed in-person visits had at least one kit request, and a total of 121 kits were distributed. Staff and clinicians found the program to be highly feasible, acceptable, and appropriate, and patient perceptions were positive.

CONCLUSIONS:

Incorporating kits in OBAT settings is an important step toward increasing patient access and utilization of life-saving services. Our program uncovered a significant unmet need among our patients, suggesting that kit integration within addiction treatment can improve the standard of care for people who use drugs.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Relacionados con Sustancias / Reducción del Daño Límite: Humans Idioma: En Revista: Harm Reduct J Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Relacionados con Sustancias / Reducción del Daño Límite: Humans Idioma: En Revista: Harm Reduct J Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos